Skip to main content
Clinical Trials/NL-OMON55595
NL-OMON55595
Completed
N/A

A randomised controlled trial to evaluate the effect of gloves containing silver fibre on burden caused by Raynaud's phenomenon in patients with systemic sclerosis - HANDS O

eids Universitair Medisch Centrum0 sites85 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Raynauds phenomenon
Sponsor
eids Universitair Medisch Centrum
Enrollment
85
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
June 11, 2021
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Age \* 18 years
  • \-Diagnosis of Systemic sclerosis according to ACR/EULAR (American College of
  • Rheumatology/European League Against Rheumatism) 2013 classification criteria
  • (total score of \* 9, including a score of 3 for the RP item)
  • \-Raynaud\*s attack frequency of at least 4 attacks per week on \* 3 different
  • days and a Raynaud Condition score (RCS) at baseline of at least 34 (on a scale
  • of 0\-100\)
  • \-Vasoactive medication (Ca antagonists, ERA, PDE5 inhibitors) should be stable
  • in the 2 weeks prior to the start of the trial
  • \-written informed consent

Exclusion Criteria

  • \- Past history of sympathectomy for Raynaud\*s phenomenon
  • \- Current treatment with iloprost, or iloprost infusion \< 6 weeks prior to
  • \- Known allergy for dyes used in textiles
  • \- Known allergy for silver fibre

Outcomes

Primary Outcomes

Not specified

Similar Trials